Coronary Balloon Products Market Survey Detailed Analysis and Forecast 2024-2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Coronary Balloon Products Market- (By Product (PTAC balloon, Nc balloon), By Material (Compliant Balloons, Non-Compliant, Semi-Compliant), By End-User (Hospitals, Cardiac Centres, Ambulatory Surgical Centres)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Coronary Balloon Products Market is valued at US$ 960.85 Mn in 2022, and it is expected to reach US$ 1188.30 Mn by 2031, with a CAGR of 2.5% during a forecast period of 2023-2031.

Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1966

Angioplasty, a minimally invasive endovascular treatment known as Coronary Balloon Products and percutaneous transluminal angioplasty (PTA), opens up restricted or blocked arteries to restore blood flow. During an angioplasty procedure, balloon-tipped catheters called angioplasty balloons compress the plaque against the arterial wall. Hospitals have redirected their staff resources from cardiac departments to other needy areas, such as emergency departments (ED) or intensive care units (ICU). These factors are expected to impact market expansion. However, this temporary slowdown in growth is projected to be followed by significant long-term growth in the market. Nonetheless, the high cost of angioplasty and post-operative complications are anticipated to hinder the market's expansion.

List of Prominent Players in the Coronary Balloon Products Market:
• Abbott Laboratories,
• Angiodynamic
• Becton Dickinson
• Biotroni
• Boston Scientific Corporation
• Braun Melsungen AG
• Cook Medical
• Cordis, Endocor GmbH
• Infinity Angioblast balloon
• Johnson & Johnson
• Koninklijke Philips N.V
• Medtronic plc
• Merit Medical System, Inc
• Oscor Inc
• Terumo Corporation.

Market Dynamics:
Drivers-
Coronary Balloon Products has replaced open surgery as the preferred way for treating patients with coronary and peripheral artery illnesses due to the rising cases of CVD and the preference for minimally invasive procedures. There is an urgent need for precise treatment options with high success rates since cardiovascular illnesses are spreading rapidly worldwide. The market for angioplasty balloons is expanding due to factors including the increasing geriatric population and the incidence of lifestyle-related illnesses. The frequency of chronic diseases, particularly cardiovascular disease, is anticipated to rise along with the ageing population, leading to an increase in hospital admissions and operations. In addition, the Coronary Balloon product market is anticipated to develop tremendously due to the growing number of innovative products that industry participants are launching to satisfy growing demand.

Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1966

Challenges:
Some patients and healthcare providers may need more awareness or understanding of Coronary Balloon Products procedures, leading to underutilization or suboptimal adoption. Reimbursement policies vary across different healthcare systems and countries. In some cases, reimbursement for Coronary Balloon Products procedures may be limited or not cover the full cost, impacting patient access to these treatments. Performing Coronary Balloon Products procedures requires skill and experience from the interventional cardiologist. In regions with limited access to experienced operators, the adoption of Coronary Balloon products may need to be improved. Coronary Balloon Products procedures can be expensive, including the cost of balloon catheters, hospital stay, medical staff, and post-operative care. The high cost of these procedures may limit accessibility for some patients or healthcare systems.

Regional Trends:
The North American Coronary Balloon Products market is projected to hold a significant market share. Elements such as a growing population, rapid urbanization, and increasing industrialization, along with extensive research and development efforts by prominent players, are expected to drive the growth of the Coronary Balloon Products market in the region. Additionally, Europe also has a substantial share of the market. Europe is renowned for its well-established healthcare infrastructure, comprising a robust network of hospitals, clinics, and cardiac care centres. This healthcare infrastructure facilitates the widespread availability and accessibility of Coronary Balloon Products products and related medical services in the region.

Recent Developments:
• In July 2021, Medtronic has just unveiled the Prevail™ drug coated balloon (DCB) Catheter in Europe subsequent to obtaining the CE (Conformité Européene) designation. The Prevail DCB, a recently developed coronary drug-coated balloon (DCB), was employed in percutaneous coronary intervention (PCI) interventions for the management of stenotic or occluded coronary arteries in individuals diagnosed with coronary artery disease (CAD).
• In November 2020, Infinity Angioplasty Balloon Co. unveiled its ground-breaking angioplasty balloon platform, the Infinity Angioplasty Balloon Catheter, after completing a first-in-human clinical trial.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1966

Segmentation of Coronary Balloon Products Market-
By Product-
• PTAC balloon
• Nc balloon
By Material-
• Compliant Balloons
• Non-Compliant
• Semi-Compliant
By End-User
• Hospitals
• Cardiac Centres
• Ambulatory Surgical Centres
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Information: https://www.insightaceanalytic.com/report/coronary-balloon-products-market/1966

Corporate Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
loaction icon
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
email iconinfo@insightaceanalytic.com
call icon
North America:
+1 551 226 6109
Asia:
+91 79 72967118

Contact Us:
Dhanraj Zurange
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.